Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rowley

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Bone Marrow Transplantation|July 1, 1996
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemiaT Demirer, F B Petersen, W I Bensinger, et al.
Blood|August 1, 1997
Allogeneic blood stem cell transplantation: considerations for donorsP Anderlini, M Körbling, D Dale, et al.
Bone Marrow Transplantation|July 15, 2009
Barriers to mental health service use among hematopoietic SCT survivorsC E Mosher, K N DuHamel, C M Rini, et al.
Blood|October 1, 1988
Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trialJ E Wagner, A D Donnenberg, S J Noga, et al.
Blood|December 1, 1996
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancyW I Bensinger, C D Buckner, K Shannon-Dorcy, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Human Gene Therapy|December 31, 1997
Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's diseaseF Schuening, W L Longo, M E Atkinson, et al.
Oncogene|August 8, 2017
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancersA N Hata, S Rowley, H L Archibald, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Bone Marrow Transplantation|July 1, 1996
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemiaT Demirer, F B Petersen, W I Bensinger, et al.
Blood|August 1, 1997
Allogeneic blood stem cell transplantation: considerations for donorsP Anderlini, M Körbling, D Dale, et al.
Bone Marrow Transplantation|July 15, 2009
Barriers to mental health service use among hematopoietic SCT survivorsC E Mosher, K N DuHamel, C M Rini, et al.
Blood|October 1, 1988
Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trialJ E Wagner, A D Donnenberg, S J Noga, et al.
Blood|December 1, 1996
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancyW I Bensinger, C D Buckner, K Shannon-Dorcy, et al.
Blood|December 10, 1999
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantationL A Holmberg, M Boeckh, H Hooper, et al.
Human Gene Therapy|December 31, 1997
Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's diseaseF Schuening, W L Longo, M E Atkinson, et al.
Oncogene|August 8, 2017
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancersA N Hata, S Rowley, H L Archibald, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Pageof 10